Curigin Inc.

www.curigin.co.kr

At Curigin, we are developing innovative therapies using our novel bi-specific shRNA technology to simultaneously knockdown two different disease causing pathways. Our lead pipelines target cancer pathways such as mTOR and STAT3 and deliver our bi-specific shRNA through an oncolytic virus genetically engineered to exclusively target and replicate in cancer cells.

Read more

Reach decision makers at Curigin Inc.

Lusha Magic

Free credit every month!

At Curigin, we are developing innovative therapies using our novel bi-specific shRNA technology to simultaneously knockdown two different disease causing pathways. Our lead pipelines target cancer pathways such as mTOR and STAT3 and deliver our bi-specific shRNA through an oncolytic virus genetically engineered to exclusively target and replicate in cancer cells.

Read more
icon

Country

icon

City (Headquarters)

Seoul

icon

Employees

11-50

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Business Development Manager

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(6)

Reach decision makers at Curigin Inc.

Free credits every month!

My account

Sign up now to uncover all the contact details